Date: Thursday 25th September 2025 | 08:30 – 17:00

Their paper is entitled: ‘From Stated Preference to Real-World Adoption: An Integrated Forecasting Approach’, and will be convened by Fenna Gloggner of Insmed Incorporated.

This paper uses the US MRI contrast agent market as a case study to present a sequential conjoint-based forecasting model, developed in collaboration with a leading global pharma company in radiology and oncology. The model integrates primary HCP preference data with historical sales trends, addressing the limitations of conventional models by simulating how preferences evolve in response to market events (e.g. new product launches, price shifts, or emerging clinical evidence).

Register now, for the 2025 EPHMRA Chapter Meeting here: https://lnkd.in/euHXF6U4